Team Photo: (c) Johannes Kremer
The Adlershof-based startup Quantune Technologies has successfully completed its seed funding round, raising an impressive €13.5 million.
The startup is developing a miniaturized laser spectrometer, the size of a chip, capable of non-invasively analyzing and measuring trace amounts of substances at the molecular level with laboratory-grade precision. This technology enables painless and injury-free monitoring of biochemical processes in the body, which until now was only possible with large and expensive lab equipment. This innovation represents a quantum leap in healthcare prevention!
The technology is set to be integrated into wearables, such as smartwatches, in the future. With the laser spectrometer, users will be able to make informed health decisions based on accurate biomarker readings.
Investors have shown great confidence in the Berlin-based startup by contributing €13.5 million in funding. The company plans to use these funds to develop a commercial biomarker measurement device for the wrist.
In addition to its successful seed round, Quantune Technologies also won this year’s KfW Founders’ Award, earning the title of state winner.
Photo: (c) Quantune.